- Home
- LEGN vs GTLB Comparison
LEGN vs GTLB Comparison
Compare LEGN & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- GTLB
- Stock Information
- Founded
- LEGN 2014
- GTLB 2011
- Country
- LEGN United States
- GTLB United States
- Employees
- LEGN N/A
- GTLB N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- GTLB EDP Services
- Sector
- LEGN Health Care
- GTLB Technology
- Exchange
- LEGN Nasdaq
- GTLB Nasdaq
- Market Cap
- LEGN 7.0B
- GTLB 7.0B
- IPO Year
- LEGN 2020
- GTLB 2021
- Fundamental
- Price
- LEGN $27.78
- GTLB $51.49
- Analyst Decision
- LEGN Strong Buy
- GTLB Strong Buy
- Analyst Count
- LEGN 13
- GTLB 23
- Target Price
- LEGN $75.67
- GTLB $71.22
- AVG Volume (30 Days)
- LEGN 1.5M
- GTLB 2.1M
- Earning Date
- LEGN 05-13-2025
- GTLB 06-02-2025
- Dividend Yield
- LEGN N/A
- GTLB N/A
- EPS Growth
- LEGN N/A
- GTLB N/A
- EPS
- LEGN N/A
- GTLB N/A
- Revenue
- LEGN $728,303,000.00
- GTLB $759,249,000.00
- Revenue This Year
- LEGN $65.96
- GTLB $26.19
- Revenue Next Year
- LEGN $52.55
- GTLB $21.91
- P/E Ratio
- LEGN N/A
- GTLB N/A
- Revenue Growth
- LEGN 112.46
- GTLB 30.93
- 52 Week Low
- LEGN $29.27
- GTLB $37.90
- 52 Week High
- LEGN $60.87
- GTLB $74.18
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- GTLB 59.03
- Support Level
- LEGN $30.25
- GTLB $50.78
- Resistance Level
- LEGN $33.30
- GTLB $54.08
- Average True Range (ATR)
- LEGN 1.78
- GTLB 1.76
- MACD
- LEGN -0.57
- GTLB 0.85
- Stochastic Oscillator
- LEGN 5.19
- GTLB 72.88
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.